92 related articles for article (PubMed ID: 6408612)
21. [RESEARCH ON FERROKINETICS IN SOME TYPES OF SECONDARY ANEMIA].
CULTRERA G; MAGLIULO E; SLAVIERO E; ZANOLLA W
Minerva Nucl; 1964; 8():6-12. PubMed ID: 14154016
[No Abstract] [Full Text] [Related]
22. The use of ferrokinetics in the study of experimental anemia.
Lee EW; Kocsis JJ; Snyder R
Environ Health Perspect; 1981 Jun; 39():29-37. PubMed ID: 7016520
[TBL] [Abstract][Full Text] [Related]
23. Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Bender-Götze C; Heinrich HC; Gabbe EE; Oppitz KH; Schröter W; Whang DH; Schäfer KH
Z Kinderheilkd; 1975; 118(4):283-301. PubMed ID: 1130121
[TBL] [Abstract][Full Text] [Related]
24. Studies on the relationship between the function of reticuloendothelial system and the hematopoiesis. II. Experimental studies on 59Fe ferrokinetics in the induced hematological disorders of mice.
Hasegawa M
Acta Med Okayama (1952); 1969 Jun; 23(3):209-18. PubMed ID: 4187584
[No Abstract] [Full Text] [Related]
25. Iron absorption in patients with chronic uraemia. A comparative study using whole body counting and red cell incorporation of radioiron.
Milman N
Scand J Haematol; 1982 Jul; 29(1):5-17. PubMed ID: 6812212
[TBL] [Abstract][Full Text] [Related]
26. [Erythropoietic rate measured by ferrokinetics].
Montz R
Nucl Med (Stuttg); 1970 Mar; 9(1):50-61. PubMed ID: 5505733
[No Abstract] [Full Text] [Related]
27. Radioisotope investigations of haematological disorders (excluding sickle cell disease) in Sierra Leone.
Knox-Macaulay HH
Afr J Med Med Sci; 1989 Mar; 18(1):75-81. PubMed ID: 2545089
[TBL] [Abstract][Full Text] [Related]
28. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
[TBL] [Abstract][Full Text] [Related]
29. The measurement of 59Fe clearance from the plasma.
Cavill I; Ricketts C; Napier JA; Jacobs A; Trevett D; Bishop RD
Scand J Haematol; 1976 Sep; 17(3):160-6. PubMed ID: 968447
[No Abstract] [Full Text] [Related]
30. [Ferrokinetics in clinical research of certain hematological disorders].
Pangaro JA; Macchi AE; Rey GJ; Goldztein SC
Prensa Med Argent; 1968 Dec; 55(43):2070-7. PubMed ID: 5732859
[No Abstract] [Full Text] [Related]
31. [Quantitative measurement of 59Fe-absorption. Comparison between iron labelled Parkevit-Fe and an iron-mono-preparation using a wholebody counter (author's transl)].
Bräuer H
MMW Munch Med Wochenschr; 1981 Jan; 123(5):181-3. PubMed ID: 6780894
[TBL] [Abstract][Full Text] [Related]
32. [Effects of radiotherapy on plasma T 1/2 59Fe in patients with lung cancer and lymphomas].
Balikdjian D; Balikdjian M; Frühling J
Strahlentherapie; 1975 Aug; 150(2):127-33. PubMed ID: 809866
[TBL] [Abstract][Full Text] [Related]
33. [Nuclear medicine studies of iron transport (ferrokinetics)].
Fueger GF
Wien Med Wochenschr; 1984 Feb; 134(3-4):70-3. PubMed ID: 6711004
[No Abstract] [Full Text] [Related]
34. The use of 59Fe for estimating red cell production and destruction: a comparative evaluation of two methods for the analysis of experimental data.
Cazzola M; Alessandrino P; Barosi G; Berzuini C; Frassoni F; Orlandi E; Stefanelli M; Perugini S
Haematologica; 1979 Dec; 64(6):696-713. PubMed ID: 121085
[No Abstract] [Full Text] [Related]
35. [Ferrokinetics].
Takahashi Y; Umadome H; Ohno Y
Nihon Rinsho; 1997 Mar; 55 Suppl 1():75-83. PubMed ID: 9097562
[No Abstract] [Full Text] [Related]
36. The combined use of iron 52 and its contaminant iron 55 in studies of the bone marrow.
O'Connell ME; Hows J; Lewis SM
Br J Radiol; 1977 Jun; 50(594):419-22. PubMed ID: 871587
[TBL] [Abstract][Full Text] [Related]
37. Role of some radioprotectors on 59Fe uptake in bone marrow after whole-body gamma irradiation to mice.
Ghose A; Basu SK; Ganguly SK; Bhatnagar A; Mathur M
Strahlentherapie; 1983 Dec; 159(12):772-4. PubMed ID: 6364458
[TBL] [Abstract][Full Text] [Related]
38. A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly.
Schümann K; Szegner B; Kohler B; Pfaffl MW; Ettle T
Toxicology; 2007 Nov; 241(1-2):19-32. PubMed ID: 17868968
[TBL] [Abstract][Full Text] [Related]
39. Ferrokinetic and hematologic studies in cystic fibrosis patients.
Wagener JS; McNeill GC; Taussig LM; Corrigan JJ; Lemen R
Am J Pediatr Hematol Oncol; 1983; 5(2):153-60. PubMed ID: 6614395
[TBL] [Abstract][Full Text] [Related]
40. The use of a whole body counter for measuring bone marrow erythroid activity by profile scanning.
Davies IH; Jacobs A; Owen GM
Int J Nucl Med Biol; 1974 Feb; 1(3):145-7. PubMed ID: 4206292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
